Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Aristotle Atlantic's Core Equity Composite delivered strong performance in Q2 2025, returning 14.30% net versus 10.94% for the S&P 500, driven primarily by security selection in technology and healthcare. The portfolio benefited...
— Mr. Fitzpatrick
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Zoetis Inc.
Zoetis Inc. is a dominant player in the animal health industry, but its capital allocation strategy has focused on share buybacks rather than organic growth. The com...
Zoetis presents a tactical investment opportunity with potential for high short-term returns due to its aggressive capital allocation strategy. The company's h...